The U.S. Supreme Court turned away on Monday a bid by Alvogen's subsidiary Norwich Pharmaceuticals to sell a generic version ...

Lipocine (LPCN) announced the publication and discussion of a manuscript “Oral LPCN 1148 Improves Sarcopenia and Hepatic Encephalopathy in Male ...

There is a growing global burden of liver disease with the current management for complications of liver cirrhosis being reactive as opposed to proactive, affecting outcomes. Management can often be ...

Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company leveraging its proprietary technology platform to augment therapeutics through effective oral delivery, today announced the publication and ...

Hepatic encephalopathy was defined according to the West-Haven criteria. [1] The episode of HE was assessed clinically and independently by two senior consultants (co-authors) with more than 20 ...

Companiesannounced the first look at its late-stage RED-C clinical trial program which will be presented at the American ...

Medicare Part D prescription drug coverage helps cover the cost of Xifaxan (rifaximin). Doctors may recommend Xifaxan to treat irritable bowel syndrome with diarrhea (IBS-D) or to help prevent overt ...

Tapering doses of corticosteroids was safer than, and just as effective as, a fixed dose in patients with severe ...

A Winnipeg woman says the health-care system is ready to abandon her seriously ill partner, who is incoherent and prone to ...

This clinical program was designed to assess the efficacy of a next generation therapeutic, a soluble solid dispersion (SSD) immediate-release rifaximin product, to delay onset of first overt hepatic ...

Symptoms that are sometimes diagnosed as part of dementia might actually be related to a treatable liver condition, according ...

"Health care providers [must be] made aware of this potential overlap between dementia and hepatic encephalopathy, which is treatable," states Virginia Commonwealth University hepatologist Jasmohan ...